John Leaman | Chief Financial Officer |
Adrian Adams | Chairman of the Board & Chief Executive Officer |
Eddie Hickman | Guggenheim Securities |
Laura Chico | Wedbush Securities |
Ladies and gentlemen, welcome to the Impel NeuroPharma Second Quarter 2021 Earnings and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Impel's Chief Financial Officer, Mr. John Leaman.